1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsOrthotics and Prosthetics Outcomes Research Program (OPORP) is sponsored by Department of Defense (DOD), U.S. Army Medical Research Acquisition Activity (USAMRAA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar DOD Orthotics and Prosthetics Outcomes, Clinical Research Award Dept.
of the Army -- USAMRAA Document Type:Grants Notice Funding Opportunity Number:W81XWH-21-OPORP-CRA Funding Opportunity Title:DOD Orthotics and Prosthetics Outcomes, Clinical Research Award Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Grant Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards:4 Assistance Listings:12.
420 -- Military Medical Research and Development Cost Sharing or Matching Requirement:No Last Updated Date:Apr 01, 2021 Original Closing Date for Applications:Jul 29, 2021 Current Closing Date for Applications:Jul 29, 2021 Archive Date:Aug 28, 2021 Estimated Total Program Funding:$ 15,000,000 Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:Dept.
of the Army -- USAMRAA Description:The FY21 OPORP CRA is intended to support clinical research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members, Veterans, and other individuals with limb loss and/or limb impairment.
Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and **inform clinical or policy decisions**. The FY21 OPORP is also interested in multidisciplinary projects that address strategies to mitigate secondary injuries.
Studies proposing or evaluating rehabilitation strategies must indicate how the rehabilitation may improve the orthotic or prosthetic device outcome when compared to standard of care. The FY21 OPORP CRA offers funding for **two Funding Levels**(Refer to Section II. D.
5, Funding Restrictions). **_Only one Funding Level category may be chosen per application, and the choice of application category is at the discretion of the applicant_**.
The following are generalized descriptions of the scope of research appropriate for each Funding Level: • **Funding Level 1**supports pilot and early-stage research studies that are exploratory and involve limited human exposure (e.g., small sample size), with the potential to make significant advancements toward clinical translation. Preliminary data are encouraged but not required for this Funding Level.
• **Funding Level 2**supports large clinical research projects that involve robust, statistically relevant participant numbers, with the potential to make significant advancement toward clinical translation.
Proposed projects may include large-scale studies that, if successful, will generate high-quality outcomes that provide strong, definitive support for evidence-based practice and/or have the potential to drive changes in clinical practice. Pragmatic studies and comparative effectiveness studies are welcome and encouraged. Preliminary data relevant to the proposed clinical study are required for this Funding Level.
Link to Additional Information:[](https://www. grants. gov/search-results-detail/332544) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes.
To continue working, click on the "OK" button below. This is being done to protect your privacy. Unsaved changes will be lost.
According to the current listing, eligibility includes: Generally open to any type of entity, including small businesses, with proposals directly relevant to Service Members and Veterans with traumatic extremity injury and/or amputation using prosthetics and orthotic devices. Confirm the full requirements in the official notice before applying.
The current listing shows varies (Phase I typically $50,000 to $250,000; Phase II $750,000 to $1.8 million). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Orthotics and Prosthetics Outcomes Research Program (OPORP) is funded by Department of Defense (DOD), U.S. Army Medical Research Acquisition Activity (USAMRAA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read article